[Prostate-specific antigen, acid phosphatases and rectal exploration in the diagnosis of prostatic cancer].
Eleven hundred and seven patients referred for urological evaluation including measurement of serumprostate specific antigen (PSA) measurement are reviewed. Prostate cancer was diagnosed in 105 patients. PSA was found to be superior to prostatic acid phosphatase in the discrimination between prostate cancer and benign prostatic conditions. In 105 patients with newly diagnosed prostate cancer, scintigraphic evidence of osseous metastases was found in thirty-seven. No patients with a serum PSA value less than three times the upper normal limit of the assay had a positive bone scan. Isotope bone scan can be omitted in these patients, if they are not considered candidates for curative treatment.
Andersen
B R
BR
Urologisk afdeling H, Amtssygehuset i Herlev.
Knorr
U B
UB
Brasso
K
K
Iversen
P
P
D000135:Acid Phosphatase / Q000378:metabolism*; D000328:Adult; D000368:Aged; D001859:Bone Neoplasms / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000556:secondary; D006801:Humans; D008297:Male; D008875:Middle Aged; D017430:Prostate-Specific Antigen / Q000032:analysis*; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000201:enzymology / Q000276:immunology / Q000473:pathology; D011877:Radionuclide Imaging; D012007:Rectum / Q000473:pathology*; D012189:Retrospective Studies
D000135:Acid Phosphatase; D017430:Prostate-Specific Antigen